Superfamily receptor chimeras, translocation assay for superfamily receptor ligands, and methods and kits for detecting and characterizing receptor ligands
OwnerGordon L. Hager, Susan MacKeminventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel superfamily receptor chimeras, methods for using superfamily receptor chimeras, methods and kits for detecting cellular function and metabolic state, and the treatment of disease states involving defective receptor protein cytoplasm/nuclear translocation. In particular, this invention is preferably directed to chimeras of glucocorticoid receptor/superfamily receptor proteins.
Claims41
A method for making a recombinant nuclear translocation protein, comprising:
- covalently connecting (i) a glucocorticoid receptor DNA sequence coding for the cytoplasmic/nuclear translocation domain of the glucocorticoid receptor protein, (ii) a superfamily receptor DNA sequence coding for the ligand binding domain of a superfamily receptor protein, and (iii) a nucleic acid sequence for a marker protein domain, to form a DNA chimera,
- wherein said superfamily receptor DNA sequence is connected to the 3′ end of said glucocorticoid receptor DNA sequence;
- and
- expressing said DNA chimera in an expression system to prepare said protein.
A protein produced by the process of:
- covalently connecting (i) a glucocorticoid receptor DNA sequence coding for the 5′ end of the DNA sequence of the glucocorticoid receptor protein, through and including the complete nuclear localization sequence and the complete helix 1 sequence of said glucocorticoid receptor DNA sequence, (ii) a superfamily receptor DNA sequence coding for the 3′ end of the DNA sequence of a superfamily receptor protein, through and including the complete ligand binding domain sequence and the complete helix 3 sequence of said superfamily receptor DNA sequence, and (iii) a nucleic acid sequence for a marker protein domain, to form a DNA chimera,
- wherein said superfamily receptor DNA sequence is connected to the 3′ end of said glucocorticoid receptor DNA sequence,
- wherein said marker protein domain DNA sequence is covalently connected to the 5′ end of said glucocorticoid receptor DNA sequence,
- and wherein said translocation domain of the glucocorticoid receptor and said ligand binding domain of a superfamily receptor are covalently connected by a DNA linker sequence;
- and
- expressing said DNA chimera in an expression system to prepare said protein.
A nucleic acid chimera comprising:
- a nucleic acid sequence which codes for the cytoplasmic/nuclear translocation domain of glucocorticoid receptor protein;
- and
- a nucleic acid sequence which codes for the ligand binding domain of a superfamily receptor protein.
A chimeric protein comprising two elements:
- a glucocorticoid receptor 5′ end, encompassing the nuclear translocation domain and helix 1;
- and
- a superfamily receptor 3′ end, encompassing the ligand binding domain and helix 3.
A method for detecting a ligand of a superfamily receptor protein, which comprises:
- producing a nucleic acid vector encoding a nucleic acid chimera comprising three elements:
- a 5′ end of a glucocorticoid receptor, encompassing the nuclear translocation domain and helix 1, a 3′ end of a superfamily receptor, encompassing the ligand binding domain and helix 3, and a nucleic acid sequence for a marker protein domain;
- transfecting a eukaryotic cell with said nucleic acid vector;
- isolating a clonal population of cells that express a chimeric protein translated from said nucleic acid vector;
- contacting said cells with a sample compound or composition;
- and
- detecting the presence of cytoplasmic/nuclear translocation in response to a ligand of said ligand binding domain.
A method for determining the concentration of a ligand of a labeled chimeric superfamily receptor protein, which comprises:
- producing a nucleic acid vector encoding a nucleic acid chimera comprising:
- a nucleic acid sequence coding for the cytoplasmic/nuclear translocation domain of glucocorticoid receptor protein, a nucleic acid sequence coding for the ligand binding domain of a superfamily receptor protein, and a nucleic acid sequence for a marker protein domain;
- transfecting a eukaryotic cell with said nucleic acid vector;
- isolating a clonal population of transfected cells that express a chimeric protein translated from said nucleic acid vector;
- contacting said transfected cells with a sample;
- scanning one or more test cell(s) to obtain signal data from said labeled protein;
- converting said signal data to obtain the cellular location of said labeled protein in said test cell(s);
- and
- analyzing said data using an analysis system having an algorithm to calculate changes in the distribution of said labeled protein between the cell cytoplasm and the cell nucleus of said test cell(s), said analysis system having the capability of providing an accurate reading of the concentration of a ligand.
A kit for detecting and screening for a ligand of a superfamily receptor protein in an environmental sample, comprising:
- a cell-based system which expresses a chimeric protein comprising the cytoplasmic/nuclear translocation domain of glucocorticoid receptor protein, the ligand binding domain of a superfamily receptor protein, and a marker protein domain;
- and
- a detection system for the detection of the translocation of said marker protein.
A kit for detecting and screening for a ligand of a superfamily receptor protein in an environmental sample, comprising:
- a quantity of a chimeric protein comprising the cytoplasmic/nuclear translocation domain of glucocorticoid receptor protein, the ligand binding domain of a superfamily receptor protein, and a marker protein domain;
- a cell-free membrane system which restricts translocation of the chimeric protein when no ligand is bound to the ligand binding domain of said chimeric protein, and which permits translocation of the chimeric protein when the ligand binding domain of said chimeric protein is bound to its ligand;
- and
- a detection system for the detection of the translocation of said marker protein.
A method for diagnosis of defects in the nuclear transportation process, which comprises:
- producing a nucleic acid vector encoding a nucleic acid chimera comprising:
- a nucleic acid sequence coding for the cytoplasmic/nuclear translocation domain of glucocorticoid receptor protein, a nucleic acid sequence coding for the ligand binding domain of a superfamily receptor protein, and a nucleic acid sequence for a marker protein domain;
- transfecting a set of suspected defective cells with said nucleic acid vector;
- isolating a clonal population of said cells that express a chimeric protein translated from said nucleic acid vector;
- contacting said cells with a ligand of said ligand binding domain;
- and
- detecting the presence or absence of cytoplasmic/nuclear translocation in response to said ligand.
A method for treating defective translocation of a superfamily receptor protein from the cytoplasm to the nucleus of a cell, in an animal in need thereof, comprising:
- producing a nucleic acid vector which is capable of being transcribed, and which encodes a nucleic acid chimera comprising:
- a nucleic acid sequence coding for the cytoplasmic/nuclear translocation domain of glucocorticoid receptor protein and a nucleic acid sequence coding for the ligand binding domain of said superfamily receptor protein;
- and
- transfecting a target cell in said animal with said nucleic acid vector.
A pharmaceutical composition comprising:
- (i) a chimeric protein comprising two elements:
- a glucocorticoid receptor 5′ end, encompassing the nuclear translocation domain and helix 1;
- and
- a superfamily receptor 3′ end, encompassing the ligand binding domain and helix 3;
- and
- (ii) a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.